BioSpace News Archive

Novel Gene Therapy Approach to Prostate Cancer Already Seeing Results in Clinical Trial and May Have Impact on Other Solid Tumor Cancers

The space will offer 1.6 million square feet of collaborative lab, office and lifestyle space.

Kezar Life Sciences, Inc. has announced the pricing of an underwritten public offering of 16,115,385 shares of its common stock, and to certain investors in lieu thereof, pre-funded warrants to purchase 2,884,615 shares of its common stock at an exercise price of $0.001 per share.

Corteva, Inc. reported financial results for the quarter ended December 31, 2019 and the full year 2019.

Evotec SE announced that its partner Bayer AG has decided to advance a further programme from the endometriosis multi-target alliance into clinical Phase I development.

Hypha Discovery Limited, the leading specialist CRO for drug metabolite provision, and Cypex Limited, experts in the provision of recombinant xenobiotic metabolising enzymes, have formed a partnership wherein Hypha can scale-up and purify metabolites made by Cypex enzymes.

Pappas Capital, a leading investor in early-stage life sciences companies, has appointed Karen LeVert as Venture Partner to help lead the expansion of the firm’s Specialized Fund Management business, with a focus on identifying attractive investment opportunities in agricultural and other related technologies.

The focus is on containment, although a number of organizations and companies are beginning work on vaccines.

In honor of Black History Month, BioSpace chose to highlight 10 African American leaders in the life sciences, individuals who have prominent roles in the life sciences and biopharmaceutical industry.

Audenz is the first-ever adjuvanted, cell-based influenza vaccine designed to protect against influenza A (H5N1) in the event of a pandemic.